Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Paper
  • Published:

Reshaping a Human Monoclonal Antibody to Inhibit Human Respiratory Syncytial Virus Infection in Vivo

Bio/Technology volume 9, pages 266–271 (1991)Cite this article

Abstract

We transferred the complementarity determining regions from a murine monoclonal antibody that neutralizes infection by respiratory syncytial virus (RSV) to a human IgG1 monoclonal antibody. The resulting reshaped human antibody lost affinity for RSV, but an additional alteration to one of the framework regions restored binding affinity and specificity. This second generation reshaped human monoclonal antibody cross-reacted with all clinical isolates of RSV tested and both prevented disease and cured mice even when administered four days after infection. We expect the antibody will prove useful in the management of this major childhood disease.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Brandt, C.D., Kim, H.W., Orrobio, J.O., Jeffries, B.C., Wood, S.C., Chanock, R.M. and Parrott, R.H. 1973. Epidemiology of respiratory syncytial virus infection in Washington DC III. Composite analysis of eleven consecutive yearly epidemics. Am. J. Epidemiol. 98: 355–364.

    Article  CAS  Google Scholar 

  2. Sims, D.G., Downham, M.A.P.S., McQuillin, J. and Gardner, P.S. 1976. Respiratory syncytial virus infection in north-east England. Br. Med. J. 2: 1095–1098.

    Article  CAS  Google Scholar 

  3. Bruhn, F.W. and Yeager, A.G. 1977. Respiratory syncytial virus in early infancy. Am. J. Dis. Child. 131: 145–148.

    Article  CAS  Google Scholar 

  4. Wright, P.F., Belshe, R.B., Kim, H.W., Van Voris, L.P. and Chanock, R.M. 1982. Administration of a highly attenuated live respiratory syncytial virus vaccine to adults and children. Infect. Immun. 37: 397–400.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Conrad, D.A., Christenson, J.C., Waner, J.L. and Marks, M.I. 1987. Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalised during an epidemic. Pediatr. Infect. Dis. J. 6: 152–158.

    Article  CAS  Google Scholar 

  6. Ogilvie, M.M., Vathenen, A.S., Radford, M., Codd, J. and Key, S. 1981. Maternal antibody and respiratory syncytial virus infection in infancy. J. Med. Virol. 7: 263–271.

    Article  CAS  Google Scholar 

  7. Hemming, V.G., Rodriguez, W., Kim, H.W., Brandt, C.D., Parrott, R.H., Burch, B., Prince, G.A., Baron, P.A., Fink, R.J. and Reaman, G. 1987. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Anti. Agents and Chemotherapy 31: 1882–1886.

    Article  CAS  Google Scholar 

  8. Hemming, V.G., Prince, G.A., Horswood, R.L., London, W.T., Murphy, B.R., Walsh, E.E., Fischer, G.W., Weisman, L.E., Baron, P.A. and Chanock, R.M. 1985. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model. J. Infect. Dis. 152: 1083–1087.

    Article  CAS  Google Scholar 

  9. Prince, G.A., Hemming, V.G., Horswood, R.L. and Chanock, R.M. 1985. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Res. 3: 193–206.

    Article  CAS  Google Scholar 

  10. Taylor, G., Stott, E.J., Bew, M., Fernie, B.F., Cote, P.J., Collins, A.P., Hughes, M. and Jebbett, J. 1983. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52: 137–142.

    Google Scholar 

  11. Stott, E.J. and Taylor, G. 1989. Immune Responses, Virus Infections and Disease, p. 85–104. N. J. Dimmock and P. D. Minor (Eds.). I.R.L. Press, London.

    Google Scholar 

  12. Benjamin, R.J., Cobbold, S.P., Clark, M.R. and Waldmann, H. 1986. Tolerance of rat monoclonal antibodies: implications for serotherapy. J. Exp. Med. 163: 1539–1544.

    Article  CAS  Google Scholar 

  13. Brüggemann, M., Winter, G., Waldmann, H. and Neuberger, M. 1989. The immunogenicity of chimeric antibodies. J. Exp. Med. 170: 2153–2157.

    Article  Google Scholar 

  14. Morrison, S.L., Johnson, M.J., Herzenberg, L.A. and Oi, V. 1984. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc. Natl. Acad. Sci. USA 81: 6851–6855.

    Article  CAS  Google Scholar 

  15. Jones, P.T., Dear, P.H., Foote, J., Neuberger, M. and Winter, G. 1986. Replacing the complementarity determining regions in a human antibody with those from a mouse. Nature 321: 522–525.

    Article  CAS  Google Scholar 

  16. Kabat, E.A., Wu, T.T., Reid-Miller, M., Perry, H.M. and Gottes-man, K.S. 1987. Sequences of proteins of immunological interest (U.S. Dept of Health and Human Services, U.S. Government Printing Office).

    Google Scholar 

  17. Saul, F.A., Amzel, M. and Poljak, R.J. 1978. Preliminary refinement and structural analysis of the Fab fragment from human immunoglob-ulin NEW. J. Biol. Chem. 253: 585–597.

    CAS  PubMed  Google Scholar 

  18. Epp, O., Colman, P., Fehlammer, H., Bode, W., Schiffer, M. and Huber, R. 1974. Crystal and molecular structure of a dimer of the variable poru'ons of the Bence-Jones protein REI. Eur. J. Biochem. 45: 513–524.

    Article  CAS  Google Scholar 

  19. Riechmann, L., Clark, M., Waldmann, H. and Winter, G. 1988. Reshaping human antibodies for therapy. Nature 332: 323–327.

    Article  CAS  Google Scholar 

  20. Nakamaya, K. and Eckstein, F. 1986. Inhibition of restriction endo-nuclease NciI cleavage by phosphothiorate groups and its application to oligonucleotide-directed mutagenesis. Nuc. Acids Res. 14: 9679–9698.

    Article  Google Scholar 

  21. Orlandi, R., Güssow, D.H., Jones, P.T. and Winter, G. 1989. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86: 3833–3837.

    Article  CAS  Google Scholar 

  22. Chothia, C. and Lesk, A.M. 1987. Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol. 196: 901–917.

    Article  CAS  Google Scholar 

  23. Steinitz, M., Klein, G., Koskimies, S. and Makela, O. 1977. EB virus induced B lymphocyte cell lines producing specific antibody. Nature 269: 420–422.

    Article  CAS  Google Scholar 

  24. Steinitz, M., Koskimies, S., Klein, G. and Makela, O. 1979. Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation. J. Clin. Lab. Immunol. 2: 1–4.

    Article  CAS  Google Scholar 

  25. Larrick, J.W. and Bourla, J.M. 1986. The prospects for the therapeutic use of human monoclonal antibodies. J. Biol. Response Modif. 5: 379–393.

    CAS  Google Scholar 

  26. James, K. and Bell, G.T. 1987. Human monoclonal antibody production. J. Immunol. Meth. 100: 5–40.

    Article  CAS  Google Scholar 

  27. Neuberger, M. 1985. Making novel antibodies by expressing trans-fected immunoglobulin genes. Trends in Biochem. Sci. 10: 347–349.

    Article  CAS  Google Scholar 

  28. Brüggeman, M., Williams, G.T., Bindon, C.I., Clark, M.R., Jefferis, R., Waldmann, H. and Neuberger, M. S. 1987. Comparison of the effector functions of human immunoglobulins using a matched set of chimaeric antibodies. J. Exp. Med. 166: 1351–1361.

    Article  Google Scholar 

  29. Neuberger, M.S., Williams, G.T. and Fox, R.O. 1984. Recombinant antibodies possessing novel effector functions. Nature 312: 604–608.

    Article  CAS  Google Scholar 

  30. Queen, C., Schneider, W.P., Selick, H.E., Payne, P.W., Landolfi, N.F., Duncan, J.F., Avdalovic, N.M., Levitt, M., Junghans, R.P. and Waldmann, T.A. 1989. A humanised antibody that binds interleukin 2 receptor. Proc. Natl. Acad. Sci. USA 86: 10029–10033.

    Article  CAS  Google Scholar 

  31. Hale, G., Clark, M.R., Marcus, R., Winter, G., Dyer, M.S., Phillips, J.M., Riechmann, L. and Waldmann, H. 1988. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody Campath-1 H. Lancet ii: 1394–1398.

    Article  Google Scholar 

  32. Kilmartin, J.V., Wright, B. and Milstein, C. 1982. Rat monoclonal antitubulin antibodies derived by using a new non-secreting rat cell line. J. Cell Biol. 93: 576–582.

    Article  CAS  Google Scholar 

  33. Favaloro, J., Treisman, R. and Kamen, R. 1980. Transcription maps of polyoma-virus specific RNA: analysis by two dimensional S1-gel mapping. Methods in Enzymol. 65: 718–749.

    Article  CAS  Google Scholar 

  34. Takahashi, N., Veda, S., Obatu, M., Nikaido, T., Nakai, S. and Honjo, T. 1982. Structure of human immunoglobulin gamma genes: implications for evolution of a gene family. Cell 29: 671–679.

    Article  CAS  Google Scholar 

  35. Hieter, P.A., Max, E.E., Seidman, J.G., Maizel, J.V., Jr. and Leder, P. 1980. Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments. Cell 22: 197–207.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. William J. Harris: Corresponding author.

Authors and Affiliations

  1. Scotgen Limited, 2 Tillydrone Avenue, Aberdeen, AB9 2TN, Scotland, UK

    Philip R. Tempest, Patricia Bremner, Frank J. Carr & William J. Harris

  2. Department of Molecular and Cell Biology, University of Aberdeen, Aberdeen, AB9 1AS, Scotland, UK

    Philip R. Tempest, Patricia Bremner, Martin Lambert & William J. Harris

  3. AFRC Institute for Animal Health, Compton, Newbury, Berkshire, RG16 ONN, UK

    Geraldine Taylor & Julie M. Furze

Authors
  1. Philip R. Tempest
    View author publications

    Search author on:PubMed Google Scholar

  2. Patricia Bremner
    View author publications

    Search author on:PubMed Google Scholar

  3. Martin Lambert
    View author publications

    Search author on:PubMed Google Scholar

  4. Geraldine Taylor
    View author publications

    Search author on:PubMed Google Scholar

  5. Julie M. Furze
    View author publications

    Search author on:PubMed Google Scholar

  6. Frank J. Carr
    View author publications

    Search author on:PubMed Google Scholar

  7. William J. Harris
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tempest, P., Bremner, P., Lambert, M. et al. Reshaping a Human Monoclonal Antibody to Inhibit Human Respiratory Syncytial Virus Infection in Vivo. Nat Biotechnol 9, 266–271 (1991). https://doi.org/10.1038/nbt0391-266

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0391-266

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing